Toujeo
Nov 28, 2019
Toujeo to treat Type 1 Diabetes; TauRx for Alzheimer’s patients
Sanofi’s Toujeo has received FDA recommendation for its expanded use in Type 1 Diabetes. Toujeo is an insulin glargine injection to control the highs and lows of blood sugar in the body. Indicated to be used in adults and paediatric patients of age six and older. Earlier, the injection was considered suitab...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
